181 related articles for article (PubMed ID: 24376712)
1. A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma.
Chakrabarti L; Wang BD; Lee NH; Sandler AD
PLoS One; 2013; 8(12):e83521. PubMed ID: 24376712
[TBL] [Abstract][Full Text] [Related]
2. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance.
Abou-Antoun TJ; Nazarian J; Ghanem A; Vukmanovic S; Sandler AD
PLoS One; 2018; 13(1):e0189711. PubMed ID: 29298329
[TBL] [Abstract][Full Text] [Related]
3. Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance.
Chakrabarti L; Abou-Antoun T; Vukmanovic S; Sandler AD
Front Oncol; 2012; 2():82. PubMed ID: 22891161
[TBL] [Abstract][Full Text] [Related]
4. Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model.
Chakrabarti L; Morgan C; Sandler AD
PLoS One; 2015; 10(6):e0129237. PubMed ID: 26079374
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway.
Wang W; Shen XB; Huang DB; Jia W; Liu WB; He YF
Cell Oncol (Dordr); 2019 Dec; 42(6):769-781. PubMed ID: 31256347
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
[TBL] [Abstract][Full Text] [Related]
7. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
8. A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2.
Annibali D; Gioia U; Savino M; Laneve P; Caffarelli E; Nasi S
PLoS One; 2012; 7(7):e40269. PubMed ID: 22848373
[TBL] [Abstract][Full Text] [Related]
9. The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system.
Lasorella A; Iavarone A
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4976-81. PubMed ID: 16549780
[TBL] [Abstract][Full Text] [Related]
10. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract][Full Text] [Related]
11. FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.
Han W; Wu Z; Zhao Y; Meng Y; Si Y; Yang J; Fu X; Yu L
Nucleic Acids Res; 2009 Jul; 37(12):3996-4009. PubMed ID: 19417068
[TBL] [Abstract][Full Text] [Related]
12. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
Hossain MM; Banik NL; Ray SK
Exp Cell Res; 2012 Aug; 318(13):1597-610. PubMed ID: 22507272
[TBL] [Abstract][Full Text] [Related]
13. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.
Lasorella A; Boldrini R; Dominici C; Donfrancesco A; Yokota Y; Inserra A; Iavarone A
Cancer Res; 2002 Jan; 62(1):301-6. PubMed ID: 11782392
[TBL] [Abstract][Full Text] [Related]
14. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
Naveen CR; Gaikwad S; Agrawal-Rajput R
Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
[TBL] [Abstract][Full Text] [Related]
15. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.
Poomthavorn P; Wong SH; Higgins S; Werther GA; Russo VC
Endocr Relat Cancer; 2009 Sep; 16(3):991-1004. PubMed ID: 19423615
[TBL] [Abstract][Full Text] [Related]
16. Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma.
Borriello A; Roberto R; Della Ragione F; Iolascon A
Haematologica; 2002 Feb; 87(2):196-214. PubMed ID: 11836171
[TBL] [Abstract][Full Text] [Related]
17. The Role of Id2 Protein in Neuroblatoma in Children.
Wieczorek A; Balwierz W
Pathol Oncol Res; 2015 Sep; 21(4):999-1004. PubMed ID: 25771836
[TBL] [Abstract][Full Text] [Related]
18. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of ID2 antagonizes arsenic trioxide-induced antitumor effects in cancer cells.
Zhang X; Lv C; Du B; Ma X; Guan J; Gao S; Li X; Zheng L; Lei L
Tumori; 2014; 100(3):352-7. PubMed ID: 25076250
[TBL] [Abstract][Full Text] [Related]
20. Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib.
Corallo D; Pastorino F; Pantile M; Mariotto E; Caicci F; Viola G; Ponzoni M; Tonini GP; Aveic S
J Exp Clin Cancer Res; 2020 Sep; 39(1):195. PubMed ID: 32962733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
